J. Sarrá

发表

Outcome and Toxicity of Salvage Treatment in Patients Relapsing After Autologous Hematopoietic Stem Cell Transplantation--Experience from a Single Center

A. Grañena, J. Berlanga, C. Ferrá, 2003, Hematology.

Incidence, clinical and biological characteristics and outcome of secondary acute lymphoblastic leukemia after solid organ or hematologic malignancy

J. Hernández-Rivas, S. Brunet, J. Ribera, 2016, Leukemia & lymphoma.

Feasibility of ESHAP + G-CSF as peripheral blood hematopoietic progenitor cell mobilisation regimen in resistant and relapsed lymphoma: a single-center study of 22 patients.

A. Grañena, J. García, J. Cancelas, 1999, Leukemia & lymphoma.

Allogeneic Transplant with Reduced Intensity Conditioning Regimens may Overcome the Poor Prognosis of B-Cell Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Variable Heavy-Chain Gene and Chromosomal Abnormalities (11q− and 17p−)

Marcos González, J. Sierra, J. S. San Miguel, 2005, Clinical Cancer Research.

Treatment with interleukin-2 (IL-2) and interferon (IFNalpha 2b) after autologous bone marrow or peripheral blood stem cell transplantation in onco-hematological malignancies with a high risk of relapse

A. Grañena, P. Vivancos, J. Sarrá, 1999, Bone Marrow Transplantation.

Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantation

C. Solano, S. Brunet, R. Martino, 2001, Bone Marrow Transplantation.

Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes.

J. Sierra, C. Solano, J. S. San Miguel, 2002, Blood.

Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols

L. Escoda, F. Solé, M. Tormo, 2015, Cancer.

Individually adjusted prophylactic donor lymphocyte infusions after CD34-selected allogeneic peripheral blood stem cell transplantation

A. Grañena, J. García, C. Ferrá, 2001, Bone Marrow Transplantation.

Prognostic significance of complex karyotype and monosomal karyotype in adult patients with acute lymphoblastic leukemia treated with risk‐adapted protocols

M. Tormo, J. Hernández-Rivas, J. Cervera, 2014, Cancer.

Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols

M. Tormo, J. Cervera, S. Brunet, 2017, Leukemia & lymphoma.

Thrombin-antithrombin complexes and prothrombin fragment 1+2 in aorto-coronary bypass surgery: relation to graft occlusion.

J. Paramo, E. Rocha, J. Rifón, 1994, Hematologic pathology.

Richter's syndrome after allogeneic stem cell transplantation for chronic lymphocytic leukaemia successfully treated by withdrawal of immunosuppression, and donor lymphocyte infusion

A. Grañena, A. Domingo, V. Romagosa, 2003, Bone Marrow Transplantation.

Impact of Next-Generation Flow (NGF) Minimal Residual Disease (MRD) Monitoring in Multiple Myeloma (MM): Results from the Pethema/GEM2012 Trial

J. Miguel, A. Órfão, N. Puig, 2017 .

Feasibility and results of subtype-oriented protocols in older adults and fit elderly patients with acute lymphoblastic leukemia: Results of three prospective parallel trials from the PETHEMA group.

L. Escoda, M. Tormo, A. Cladera, 2016, Leukemia research.

Religious Affiliations and Ethical Opinions of Students at Xavier University School of Medicine, Aruba

Gabriel E Andrade, Saleh Khasawneh, J. Sarrá, 2018 .

Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial

J. Esteve, M. Tormo, Marcos González, 2010, Haematologica.

Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard and high risk myeloma.

J. Martinez-Climent, A. Órfão, N. Puig, 2020, Blood.

Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial.

J. Esteve, L. Escoda, M. Tormo, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allogeneic peripheral blood stem cell transplantation with reduced‐intensity conditioning: results of a prospective multicentre study

C. Solano, J. S. San Miguel, R. Martino, 2001, British journal of haematology.

Mobilization of peripheral stem cells with intensive chemotherapy (ICE regimen) and G-CSF in chronic myeloid leukemia.

A. Grañena, A. Aventín, E. de la Banda, 1996, Bone marrow transplantation.

Mobilization of Hematopoietic Stem Cells into Peripheral Blood for Autologous Transplantation Seems Less Efficacious in Poor Mobilizers with the Use of a Biosimilar of Filgrastim and Plerixafor: A Retrospective Comparative Analysis

J. Ribera, S. Ortega, A. Sureda, 2020, Oncology and Therapy.

Elderly age and prior autologous transplantation have a deleterious effect on survival following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results from the Spanish multicenter prospective trial

C. Solano, J. Besalduch, J. Pérez-Simón, 2004, Bone Marrow Transplantation.

Umbilical cord blood transplantation from unrelated donors in an adult weighing 90 kilograms. Role of immunosuppression in engraftment

E. González-Barca, A. Grañena, G. Sirchia, 1997, Bone Marrow Transplantation.

Renal involvement in non-malignant IgM gammopathy.

A. Domingo, R. Poveda, J. Grinyó, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Renal involvement in nonmalignant IgM gammopathy

A. Domingo, R. Poveda, J. Grinyó, 2007 .

Multiple myeloma and hyperammonemic encephalopathy: review of 27 cases.

O. Gasch, J. Lora-Tamayo, R. Pujol, 2008, Clinical lymphoma & myeloma.

Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL): real-life experience with long-term outcomes, toxicities and responses to second-line therapies

E. González-Barca, J. Ribera, E. Domingo-Domènech, 2022, International Journal of Hematology.

Lack of negative impact of Philadelphia chromosome in older patients with acute lymphoblastic leukaemia in the thyrosine kinase inhibitor era: comparison of two prospective parallel protocols

M. Tormo, A. Oriol, S. Brunet, 2012, British journal of haematology.

Development and psychometric validation of a brief comprehensive health status assessment scale in older patients with hematological malignancies: The GAH Scale.

E. González-Barca, Mar Durán, S. Bonanad, 2015, Journal of geriatric oncology.

Treatment with daratumumab in patients with relapsed/refractory AL amyloidosis: a multicentric retrospective study and review of the literature

E. Askari, R. Lecumberri, M. Cibeira, 2020, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Allogeneic Transplant in Patients with Poor Prognosis B-Chronic Lymphocytic Leukemia (B-CLL): Comparative Study between Myeloablative(M) and Non-Myeloablative(NM) Conditioning Regimen.

J. Esteve, R. Martino, J. Díez, 2004 .

Bendamustine, bortezomib and prednisone for the treatment of patients with newly diagnosed multiple myeloma: results of a prospective phase 2 Spanish/PETHEMA trial

Á. Payer, J. Miguel, N. Puig, 2015, Haematologica.

Liver Infiltration In Splenic Marginal Zone Lymphoma: Prevalence and Prognostic Implication

V. Romagosa, E. González-Barca, S. Mercadal, 2010 .

Genetic variants of CTLA4 are associated with clinical outcome of patients with multiple myeloma

L. Escoda, A. Oriol, A. Sureda, 2023, Frontiers in Immunology.

Demonstration of Epstein-Barr virus in a case of multiple myeloma after renal transplantation.

V. Romagosa, A. Domingo-Clarós, A. Grañena, 2000, Haematologica.

Long‐Term disease‐free survival in a primary plasma cell leukemia treated by VAD, autologous PBSC transplantation, and IFN‐α

A. Grañena, A. Domingo, C. Ferrá, 2002, American journal of hematology.